-
Je něco špatně v tomto záznamu ?
Association of α-1-Antichymotrypsin Expression with the Development of Conformational Changes of Tau Protein in Alzheimer's Disease Brain
PH. Horta-López, G. Mendoza-Franco, F. Rodríguez-Cruz, FM. Torres-Cruz, E. Hernández-Echeagaray, JJ. Jarero-Basulto, J. Rícny, B. Florán Garduño, F. Garcia-Sierra
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- Alzheimerova nemoc * metabolismus MeSH
- lidé MeSH
- mozek metabolismus MeSH
- neurofibrilární klubka metabolismus patologie MeSH
- neurony metabolismus MeSH
- proteiny tau metabolismus MeSH
- protilátky MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
In Alzheimer's disease (AD), two mutually exclusive amino-terminal-dependent conformations have been reported to occur during the aggregation of Tau protein into neurofibrillary tangles (NFTs). An early conformation of full-length Tau, involving the bending of the amino terminus over the third repeated domain, is recognized by the Alz-50 antibody, followed by a second conformation recognized by Tau-66 antibody that depends on the folding of the proline-rich region over the third repeated domain in a molecule partially truncated at the amino- and carboxyl-termini. α-1-antichymotrypsin (ACT) is an acute phase serum glycoprotein that accumulates abnormally in the brain of AD patients, and since it is considered to promote the in vitro and in vivo aggregation of amyloid-β, we here seek further evidence that ACT may also contribute to the abnormal aggregation of Tau in AD. By analyzing brain samples from a population of AD cases under immunofluorescence and high-resolution confocal microscopy, we demonstrate here the abundant expression of ACT in hippocampal neurons, visualized as a granular diffuse accumulation, frequently reaching the nuclear compartment. In a significant number of these neurons, intracellular NFTs composed of abnormally phosphorylated and truncated Tau at Asp421 were also observed to coexist in separated regions of the cytoplasm. However, we found strong colocalization between ACT and diffuse aggregates of Tau-66-positive granules, which was not observed with Alz-50 antibody. These results suggest that ACT may play a role during the development of Tau conformational changes facilitating its aggregation during the formation of the neurofibrillary pathology in AD.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23011461
- 003
- CZ-PrNML
- 005
- 20230801133047.0
- 007
- ta
- 008
- 230718s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.neuroscience.2022.01.002 $2 doi
- 035 __
- $a (PubMed)35007692
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Horta-López, Perla H $u Department of Physiology, Biophysics and Neurosciences, Center for Research and Advanced Studies of the National Polytechnic Institute, Mexico City, Mexico
- 245 10
- $a Association of α-1-Antichymotrypsin Expression with the Development of Conformational Changes of Tau Protein in Alzheimer's Disease Brain / $c PH. Horta-López, G. Mendoza-Franco, F. Rodríguez-Cruz, FM. Torres-Cruz, E. Hernández-Echeagaray, JJ. Jarero-Basulto, J. Rícny, B. Florán Garduño, F. Garcia-Sierra
- 520 9_
- $a In Alzheimer's disease (AD), two mutually exclusive amino-terminal-dependent conformations have been reported to occur during the aggregation of Tau protein into neurofibrillary tangles (NFTs). An early conformation of full-length Tau, involving the bending of the amino terminus over the third repeated domain, is recognized by the Alz-50 antibody, followed by a second conformation recognized by Tau-66 antibody that depends on the folding of the proline-rich region over the third repeated domain in a molecule partially truncated at the amino- and carboxyl-termini. α-1-antichymotrypsin (ACT) is an acute phase serum glycoprotein that accumulates abnormally in the brain of AD patients, and since it is considered to promote the in vitro and in vivo aggregation of amyloid-β, we here seek further evidence that ACT may also contribute to the abnormal aggregation of Tau in AD. By analyzing brain samples from a population of AD cases under immunofluorescence and high-resolution confocal microscopy, we demonstrate here the abundant expression of ACT in hippocampal neurons, visualized as a granular diffuse accumulation, frequently reaching the nuclear compartment. In a significant number of these neurons, intracellular NFTs composed of abnormally phosphorylated and truncated Tau at Asp421 were also observed to coexist in separated regions of the cytoplasm. However, we found strong colocalization between ACT and diffuse aggregates of Tau-66-positive granules, which was not observed with Alz-50 antibody. These results suggest that ACT may play a role during the development of Tau conformational changes facilitating its aggregation during the formation of the neurofibrillary pathology in AD.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a Alzheimerova nemoc $x metabolismus $7 D000544
- 650 _2
- $a proteiny tau $x metabolismus $7 D016875
- 650 _2
- $a neurofibrilární klubka $x metabolismus $x patologie $7 D016874
- 650 _2
- $a neurony $x metabolismus $7 D009474
- 650 _2
- $a mozek $x metabolismus $7 D001921
- 650 _2
- $a protilátky $7 D000906
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Mendoza-Franco, Graciela $u Department of Cell Biology, Center for Research and Advanced Studies of the National Polytechnic Institute, Mexico City, Mexico
- 700 1_
- $a Rodríguez-Cruz, Fanny $u Department of Cell Biology, Center for Research and Advanced Studies of the National Polytechnic Institute, Mexico City, Mexico
- 700 1_
- $a Torres-Cruz, Francisco M $u Laboratorio de Neurofisiología del Desarrollo y la Neurodegeneración, UBIMED, FES-Iztacala, Universidad Nacional Autónoma de México, Ciudad de México, Mexico
- 700 1_
- $a Hernández-Echeagaray, Elizabeth $u Laboratorio de Neurofisiología del Desarrollo y la Neurodegeneración, UBIMED, FES-Iztacala, Universidad Nacional Autónoma de México, Ciudad de México, Mexico
- 700 1_
- $a Jarero-Basulto, Jose J $u Cellular Neurobiology Laboratory, Cell and Molecular Biology Department, CUCBA, University of Guadalajara, Zapopan, Mexico
- 700 1_
- $a Rícny, Jan $u National Institute of Mental Health, Klecany, Czech Republic
- 700 1_
- $a Florán Garduño, Benjamín $u Department of Physiology, Biophysics and Neurosciences, Center for Research and Advanced Studies of the National Polytechnic Institute, Mexico City, Mexico. Electronic address: bfloran@fisio.cinvestav.mx
- 700 1_
- $a Garcia-Sierra, Francisco $u Department of Cell Biology, Center for Research and Advanced Studies of the National Polytechnic Institute, Mexico City, Mexico. Electronic address: f.garcia.sierra@cinvestav.mx
- 773 0_
- $w MED00003505 $t Neuroscience $x 1873-7544 $g Roč. 518, č. - (2023), s. 83-100
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35007692 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230718 $b ABA008
- 991 __
- $a 20230801133044 $b ABA008
- 999 __
- $a ok $b bmc $g 1963709 $s 1197726
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 518 $c - $d 83-100 $e 20220108 $i 1873-7544 $m Neuroscience $n Neuroscience $x MED00003505
- LZP __
- $a Pubmed-20230718